LOTAGEN SOLUTION
LOTAGEN SOLUTION
Authorised
- Policresulen
Product identification
Medicine name:
LOTAGEN SOLUTION
Active substance:
- Policresulen
Target species:
-
Cattle
-
Pig
-
Cat
-
Horse
-
Horse (mare)
-
Sheep
-
Goat
-
Dog
Route of administration:
-
Cutaneous use
Product details
Active substance and strength:
-
Policresulen360.00/milligram(s)1.00gram(s)
Pharmaceutical form:
-
Cutaneous solution
Withdrawal period by route of administration:
-
Cutaneous use
-
Cattle
-
Meat and offal0day
-
Milk0day
-
-
Pig
-
Meat and offal0day
-
-
Horse
-
Meat and offal0day
-
-
Horse (mare)
-
Milk0day
-
-
Sheep
-
Meat and offal0day
-
Milk0day
-
-
Goat
-
Milk0day
-
Meat and offal0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QD08AE02
Legal status of supply:
-
Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
France
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Intervet
Marketing authorisation date:
Manufacturing sites for batch release:
- Schering Plough (Bray)
- Trirx Segre
Responsible authority:
- French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
- FR/V/4905252 5/1992
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 4/04/2022